REGISTERED
on 23 Aug 2022
Last Applicant/ Owned by
2200 Pennsylvania Ave. NW
Washington
DC
20037
Serial Number
90288233 filed on 29th Oct 2020
Registration Number
6828605 registered on 23rd Aug 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
HETLIOZ LQ
Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhyt Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation
First Use Date in General
28th Aug 2020
First Use Date in Commerce
01st Dec 2020
Mark Details
Serial Number
No 90288233
Mark Type
No Service/Collective Mark
Attorney Docket Number
No VAND-0217-TM
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 21st Jul 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 20th Jul 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 28th Jun 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Jun 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 27th Jun 2022 | SOU EXTENSION 2 GRANTED |
| 27th Jun 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 17th Jun 2022 | USE AMENDMENT FILED |
| 17th Jun 2022 | SOU EXTENSION 2 FILED |